RA
KMTS

RiverPark Advisors’s Kestra Medical Technologies KMTS Stock Holding History

RiverPark Advisors’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.7K Sell
1,742
-22
-1% -$519 0.01% 144
2025
Q4 		$46.8K Buy
+1,764
New +$45.4K 0.01% 142

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RiverPark Advisors's KMTS Position: Q1 2026 in Review

RiverPark Advisors reduced its Kestra Medical Technologies (KMTS) stake by 1.2% in Q1 2026, selling an estimated $519 and leaving 1,742 shares worth $34.7K. The position accounts for 0.01% of the portfolio, ranked #144.

RiverPark Advisors first reported a position in KMTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $46.8K in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • RiverPark Advisors held 1,742 shares of Kestra Medical Technologies worth $34.7K as of Q1 2026.
  • RiverPark Advisors sold 22 Kestra Medical Technologies shares in Q1 2026, an estimated $519.
  • Kestra Medical Technologies made up 0.01% of RiverPark Advisors's portfolio in Q1 2026, its #144 holding.
  • RiverPark Advisors first reported a position in Kestra Medical Technologies in Q4 2025 and has held it in 2 quarters since.
  • RiverPark Advisors's Kestra Medical Technologies position peaked at $46.8K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.